The general lack of correlation between proviral status and expression levels in end-stage tumors could reflect tumor heterogeneity, which is supported by Southern blotting analyses, and/or that consequences of Cd74 deregulation are manifested at a stage earlier on in the progression of the tumors. The gene discussed is CD74; the disease is neoplasm.